It was a busy, happy, and happening year here at IJD^®^. The year started with two exciting, significant, and almost successive developments. Both, I am sure, will go a long way in defining and shaping the future of this heritage journal.

*Indian Journal of Dermatology* (IJD^®^) became the official organ of Asian Academy of Dermatology and Venereology (AADV). For the oldest surviving journal of dermatology from Asia, this was probably natural to happen. Volume wise too, there was a sudden, almost tenfold expansion. IJD^®^ started reaching almost all the qualified dermatologists in the country with the aid of a gracious academic grant from Ranbaxy.

Technically, another milestone was achieved when we had been able to finalize the registration process of IJD^®^ as our official trade mark.

For any journal of international repute, punctuality of publication is of utmost importance. I am happy to mention that we were able to bring out all the issues of 2012 dot on time.

There has also been a steep rise in article submission in IJD^®^. We receive about 2.054 articles per day. Till today, this year, we have received 736 articles from all over the globe -- a quantum jump of 38.83% as compared to last year. One out of every three articles (about 36%) submitted this year were from abroad.

The quality of any academic journal depends on the number of original articles published in it. In the last couple of years, we have witnessed a phenomenal increase in the rate of submission of original articles to IJD^®^. From 65 in 2010, this year we have received 130 original articles, which is a stupendous 100% increase. 48% of our original articles have been submitted from abroad this year.

Thanks to our efficient editorial team, responsive reviewers, and proficient publishers, we were able to transform the whole review process to make it very fast and efficient. The time taken from first submission to acceptance and from acceptance to publication has come down to 149 and 37 days from 282 and 139 days, respectively.

IJD Symposium has already become an important identity of IJD^®^ since it was first introduced in 2009. In 2012, we could bring out two high-quality symposia on Polymyositis-Dermatomyositis and Pediatric Dermatology, respectively. We thank Dr. Siba Prasad Raychaudhuri and Dr. Deepak Parikh for graciously accepting the offer to be our guest editors. In this issue, we are publishing an outstanding symposium on Psychodermatology edited by Dr. Shruthakirti D Shenoy, the first of its kind in any Indian journal. Some more interesting symposia are in the pipeline.

We, at IJD^®^, maintain a strict principle of absolute zero tolerance in matters related to plagiarism. In the recent past, we have retracted a few articles and punished some authors for their academic dishonesty by banning them.

The load of accepted but unpublished articles is uncomfortably huge. To accommodate these quality articles, we have introduced electronic publication of case reports in every issue. The pdf of these articles are downloadable by our members and subscribers in India and can be referenced like any other article, but these will not be printed in the hardcopy version of the journal -- only the title and names of the authors will be mentioned.

The process of submitting clinical trial reports in IJD has undergone some significant changes very recently. We have incorporated the hyperlink to the most recent CONSORT Statement in our "Instruction to Authors" (<http://www.e-ijd.org/contributors.asp>) and have advised all prospective trial report authors to adhere to the same. For more details, you may please go through the excellent and elaborate annotation by my esteemed colleagues, Executive Editor Dr. Saumya Panda and Prof. Hywell Williams, Special Advisor, Clinical trials, respectively.

Honestly, it was not an easy task to fit into the shoes of my illustrious predecessor Dr. Sandipan Dhar who has given his heart and soul for the improvement of the journal. His affectionate support and guidance is a source of sustenance for me. Although the outcome is not always directly proportional to the effort exerted, still I have tried to offer the best that I can, with the help of the highly erudite, focused, and committed editorial board members, distinguished members of the editorial advisory board, and extremely supportive executive committee of IADVL, WB.

I take this opportunity to thank our sponsors, namely Ranbaxy, Galderma, Palsons Derma, Ajanta (Zillion and Avecea), Gracewell, and Ipca Bionova, who stood by us like rocks.

Before I sign off, on behalf of team IJD^®^, let me wish all of you a very happy, healthy, peaceful, prosperous, and productive 2013.

Long live the *Indian Journal of Dermatology* (IJD^®^)!
